Lest you all forget
Dr. Scheier is a specialist in intensive care medicine and anesthesiology, with more than 15 years of combined experience in treating critically-ill patients and in the design and execution of clinical trials in critical care and cardiac medical devices in Germany. Dr. Scheier joins CytoSorbents from SORIN Group, a global leader in cardiac surgery, where he served as Country Manager of Clinical Operations in Germany and led the implementation of SORIN's international clinical development and operations strategy in the country. Prior to that, he was Director of Medical Innovation and former Medical Manager of Critical Care at PULSION Medical Systems, a leader in intensive care unit (ICU) hemodynamic monitoring, acquired by Maquet Getinge Group in 2014.
Dr. Scheier brings to CytoSorbents a well-established key opinion leader network in critical care and cardiac surgery, and a wealth of experience in clinical trial design and management of both sponsor and investigator-initiated medical device clinical studies, both before and after approval. In addition, as a veteran of clinical operations and industry, he brings a diverse set of skills and expertise in regulatory affairs, medical advisory board management, product safety monitoring, sales and marketing training and support, reimbursement, project management, and the identification and evaluation of promising future technologies.
Dr. Joerg Scheier remarked, "Since starting with CytoSorbents, I have already spoken to many physicians who are seeing CytoSorb® treatment work first-hand in very difficult cases and can see their energy and enthusiasm for the therapy. My goal at CytoSorbents is to foster and grow the medical and health economics data around CytoSorb® therapy and make it a routine first-line choice by physicians to treat their patients. I truly believe that CytoSorb® has the potential to re-define critical care as a novel therapy for life-threatening conditions and holds great promise
